Abstract
The use of psychotropic medications has increasingly become part of comprehensive treatment plans for children and adolescents. Due to the paucity of research, however, pediatric psychopharmacology is more an art than a science. Most rigorous pharmacological studies have focused on attention-deficit hyperactivity disorder (ADHD), and there are clear indications for stimulants as the primary therapy. However, there are fewer and less rigorous well controlled studies of antidepressants in children and adolescents, and even fewer in number and less well designed studies of antianxiety or anxiolytic medications. Thus, recommendations for using them in treatment are not as clear as for ADHD. Despite the lack of rigorous data, psychotropics are increasingly used. Factors contributing to this trend are diverse, including increasing severity of juvenile psychopathology, school mandates to educate youths who have serious psychiatric disorders, parents, and the inability of communities to manage their children's problems sufficiently, lack of appropriate alternative services, the availability of more effective medications that have relatively benign side effects, and pressure to contain costs from managed care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Addington, D. E., Jones, B., Bloom, D., Chouinard, G., Remington, G., & Albright, P. (1993). Reduction of hospital days in chronic schizophrenic patients treated with risperidone: A retrospective study. Clinical Therapy, 15, 917–926.
Akiskal, H. S., Downs, J., Jordan, P., Watson, S., Daugherty, D., & Pruitt, D. B. (1985). Affective disorders in referred children and younger siblings of manic depressives. Archives of General Psychiatry, 42, 996–1003.
American Academy of Pediatrics, Committee on Bioethics (1995). Informed consent, parental permission, and assent in pédiatrie practice. Pediatrics, 95, 314–317.
Bernstein, G., Borchard, C, & Perwein, A. (1996). Anxiety disorders in children and adolescents: A review of the past ten years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1110–1119.
Biederman, J., Thisted, R. A., Greenhill, L. L., & Ryan, N. D. (1995). Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year-old children. Journal of Clinical Psychiatry, 56, 87–93.
Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A., Kaufman, J., Dahl, R. E., Perel, J., & Nelson, B. (1996a). Childhood and adolescent depression: A review of the past 10 years. Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1427–1439.
Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A., & Kaufman, J. (1996b). Childhood and adolescent depression: A review of the past 10 years. Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1575–1583.
Birmaher, B., Waterman, G. S., Ryan, N., Cully, M., Balach, L., Ingram, J., & Brodsky, M. (1994). Fluoxetine for childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 993–999.
Bradley, C. (1937). Behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577–585.
Campbell, M., Silva, R. R., Kafantaris, V., Locascio, J. J., Gonzalez, N. M., Lee, D., & Lynch, N. S. (1991). Predictors of side effects associated with lithium administration in children. Psychopharmacology Bulletin, 27, 373–380.
Cantwell, D. P. (1996). Attention deficit disorder: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 978–987.
Cantwell, D. P., Swanson, J., & Conners, D. F. (1997). Case study: Adverse response to clonidine. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 539–544.
Carlson, G. A., & Weintraub, S. (1993). Childhood behavior problems and bipolar disorder: Relationship or coincidence? Journal of Affective Disorders, 28, 143–153.
Carrey, N. J., Wiggins, D. M., & Milin, R. P. (1996). Pharmacological treatment of psychiatric disorders in children and adolescents: Focus on guidelines for the primary care practitioner. Drugs, 51, 750–759.
Cauffman, E., & Steinberg, L. (1995). The cognitive and affective influences on adolescent decision making. Temple Law Review, 68, 1763–1789.
Chappell, P. B., Riddle, M. A., Scahill, L., Lynch, K. A., Schultz, R., Arnsten, A., Leckman, J. F., & Cohen, D. J. (1995). Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1140–1146.
Committee on Bioethics (1995). Informed consent, parental permission, and assent in pédiatrie practice. The American Academy of Pediatrics, 95, 314–317.
Conners, C. K., Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, A., Weller, R. A., Khayrallah, M., & Ascher, J. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314–1321.
Dahl, R. E., Ryan, N. D., Puig-Antich, J., Nguyen, N. A., al-Shabbout, M, Meyer, V. A., & Perel, J. (1991). 24-hour cortisol measures in adolescents with major depression: A controlled study. Biological Psychiatry, 30(1), 25–36.
DeVaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Greist, J. H., Reichler, R., Katz, R.,’ Landau, P. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: A multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 45–49.
Dulcan, M. (1997). Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 56(10 Supplement), 85S–121S.
Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., & Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031–1307.
Famularo, R., Kinscherff, R., & Fenton, T. (1988). Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. American Journal of Diseases of Children, 142, 1244–1247.
Faraone, S. V., Biederman, J., Wozniak, J., Mundy, E., Mennin, D., & O’Donnell, D. (1997). Is comorbidity with ADHD a marker for juvenile-onset mania? Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1046–1055.
Feldman, H., Crumrine, P., Handen, B. L., Alvin, R., & Teodori, J. (1989). Methylphenidate in children with seizures and attention-deficit disorder. American Journal of Diseases of Children, 143, 1081–1086.
Ferreri, M., & Hantouche, E. G. (1998). Recent trials of hydroxyzine in generalized anxiety disorder. Ada Psychiatrica Scandinavica, Supplementum, 393, 102–108.
Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Grossman, S. (1999). Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Archives of General Psychiatry, 56, 330–336.
Garland, E. J. (1998). Intranasal abuse of prescribed methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1242–1243.
Geller, B. (1997). Double-blind placebo-controlled study of lithium for adolescents with comorbid bipolar and substance dependency disorders. Presented at the Annual Midyear Institute of the American Academy of Child and Adolescent Psychiatry, March 19-21, Hamilton, Bermuda.
Geller, B., Cooper, T. B., Chestnut, E. C, Abel, A. S., & Anker, J. A. (1984). Nortriptyline pharmacokinetic parameters in depressed children and adolescents: Preliminary data. Journal of Clinical Psychopharmacology, 4, 265–269.
Geller, B., Cooper, T. B., & Chestnut, E. C. (1985). Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents: Preliminary data. Journal of Clinical Psychopharmacology, 5, 213–216.
Geller, B., Cooper, T. B., Zimerman, B., Sun, K., Williams, M., & Frazier, J. (1994a). Double-blind placebo-controlled study of lithium for depressed children with bipolar family histories. Neumpsychopharmacology, 10(S-122), 541S.
Geller, B., & Fetner, H. H. (1989). Children’s 24-hour serum lithium level after a single dose predicts initial dose and steady-state plasma level. Journal of Clinical Psychopharmacology, 9, 155.
Geller, B., Fox, L. W., & Clark, K. A. (1994b). Rate and predictors of prepubertal bipolarity during follow-up of 6-to 12-year-old depressed children. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 461–468.
Geller, B., Fox, L. W., & Fletcher, M. (1993). Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6-to 12-year-olds. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 43–50.
Geller, B., & Luby, J. (1997). Child and adolescent bipolar disorder: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1168–1176.
Geller, B., Sun, K., Zimmerman, B., Luby, J., Frazier, J., & Williams, M. (1995). Complex and rapid-cycling in bipolar children and adolescents: A preliminary study. Journal of Affective Disorders, 34, 259–268.
Goldman-Rakic, C. P., & Brown, R. M. (1982). Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Developmental Brain Research, 4, 339–349.
Grcevich, S. J., Findling, R. L., Rowane, W. A., Friedman, L., & Schulz, S. C. (1996). Risperidone in the treatment of children and adolescents with schizophrenia: A retrospective study. Journal of Child and Adolescent Psychopharmacology, 6, 251–257.
Gutgesell, H., Atkins, D., Barst, R., Buck, M., Franklin, W, Humes, R., Ringel, R., Shaddy, R., & Taubert, K. A. (1999). Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation, 99, 979–982.
Hagino, O. R., Weiler, E. B., Weiler, R. A., Washing, D., Fristad, M. A., & Kontras, S. B. (1995). Untoward effects of lithium treatment in children aged four through six years. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1584–1590.
Hanna, G. L., Feibusch, E. L., & Albright, K. J. (1997). Buspirone treatment of anxiety associated with pharyngeal dysphasia in a four-year-old. Journal of the American Academy of Child and Adolescent Psychiatry, 7137–143.
Harmon, R. J., & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–1249.
Horrigan, J. P. (1996). Guanfacine for PTSD nightmares. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 975–976.
Hyman, S. E., & Nestler, E. J. (1996). Initiation and adaptation: A paradigm for understanding psychotropic drug action. American Journal of Psychiatry, 153, 151–162.
Isojarvi, J. I., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K. T., & Myllyla, V. V. (1993). Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine, 329, 1383–1388.
Jakala, P., Riekkinen, M., Sirvio, J., Koivisto, E., Kejonen, K., Vanhanen, M, & Riekkinen, P., Jr. (1999). Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neumpsychopharmacology, 20, 460–470.
Joshi, P. T., Hamel, L., Joshi, A. R., & Capozzoli, J. A. (1998). Use of droperidol in hospitalized children. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 228–230.
Kelly, D. L., Conley, R. R., Love, R. C, Horn, D. S., & Ushchak, C. M. (1998). Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months. Journal of Child and Adolescent Psychopharmacology, 8, 151–159.
King, R. A., Riddle, M. S., Chappell, P. B., Hardin, M. T., Anderson, G. M, Lombroso, P., & Scahill, L. (1991). Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 179–186.
Kingsbury, S. J., & Tekell, J. L. (1999). What are the advantages and disadvantages of using different providers for psychotherapy and drug treatment? Harvard Mental Health Letter, 15(11), 8.
Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1995). Naltrexone in young autistic children: A double-blind, placebo-controlled crossover study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 223–231.
Kovacs, M., & Gatsonis, C. (1994). Secular trends in age at onset of major depressive disorder in a clinical sample of children. Journal of Psychiatric Research, 28, 319–329.
Kovacs, M., & Pollock, M. (1995). Bipolar disorder and comorbid conduct disorder in childhood and adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 715–723.
Kuperman, S., & Stewart, M. A. (1987). Use of propranolol to decrease aggressive outbursts in younger patients. Open study reveals potentially favorable outcome. Psychosomatics, 28, 315–319.
Leonard, H. L., March, J., Rickler, K. C, & Allen, A. J. (1997). Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 725–736.
Leonard, H. L., Meyer, M. C, Swedo, S. E., Richter, D., Hamburger, S. D., Allen, A. J., Rapoport, J. L., & Tucker, E. (1995). Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1460–1468.
Lombroso, P. J., Scahill, L., King, R. A., Lynch, K. A., Chappell, P. B., Peterson, B. S., McDougle, C. J., & Leckman, J. F. (1995). Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1147–1152.
March, J., Biederman, J., Wolkow, R., & Safferman, A. (1998). Sertraline in children and adolescents with obsessive compulsive disorder: A multicenter double-blind placebo-controlled study. Journal of the American Medical Association, 280, 1752–1756.
March, J. S., Kobak, K. A., Jefferson, J. W., Mazza, J., & Greist, J. H. (1990). A double-blind, placebo-controlled trial of fluroxamine versus impramine in outpatients with major depression. Journal of Clinical Psychiatry, 51, 200–202.
Myers, K., & McCauley, E. (1997). Treatment of depressive disorders during adolescence. In D. L. Dunner (Ed.), Current psychiatric therapy II, 2nd ed. (pp. 458–467). Philadelphia: W.B. Saunders.
Neumann, P. J. (1999). Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: Implications for schizophrenia treatment. Journal of Clinical Psychology, 60(Suppl 3), 9–14, discussion 15.
Papatheodorou, G., & Kutcher, S. P. (1993). Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacology, 29, 213–219.
Pfeffer, C. R., Jiang, H., & Domeshek, L. J. (1997). Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. Journal of Child and Adolescent Psychopharmacology, 7, 145–155.
Pizzuti, D. (1999, June). Cylert (pemoline) patient information/consent form. Abbott Pharmaceutical Products Division, 99F–110–6993A.
Preskorn, S. H., Bupp, S. J., Weiler, E. B., & Weiler, R. A. (1989). Plasma levels of imipramine and metabolites in 68 hospitalized children. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 373–375.
Richman, N. (1985). A double-blind drug trial of treatment in young children with waking problems. Journal of Child Psychology and Psychiatry and Allied Disciplines, 26, 591–598.
Riddle, M. A., Brown, N., Dzubinski, D., Jetmalani, A. N., Law, Y., & Woolston, J. L. (1989). Fluoxetine overdose in an adolescent. Journal of the American Academy of Child and Adolescent Psychiatry, 23, 587–588.
Riddle, M. A., Claghorn, J., Gaffney, G., et al. (1996). Fluvoxamine for children and adolescents with OCD: A controlled multicenter trial. Presented at the 43rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 25, Philadelphia.
Riddle, M. A., Nelson, J. C, Kleinman, C. S., Rasmusson, A., Leckman, J. F., King, R. A., & Cohen, D. J. (1991). Sudden death in children receiving Norpramin: A review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 104–108.
Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., Smith, J. C, Leckman, J. F., & Cohen, D. J. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1062–1069.
Rosenberg, D. R., Stewart, C. M., Fitzgerald, K. D., Tawile, V., & Carroll, E. (1999). Paroxetine open-label treatment of pédiatrie outpatients with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1180–1185.
Rosenheck, R., Cramer, J., Allan, E., Erdos, J., Frisman, L. K., Xu, W., Thomas, J., Henderson, W., & Charney, D. (1999). Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on clozapine in refractory schizophrenia. Archives of General Psychiatry, 56, 565–572.
Ryan, N. D. (1992). The pharmacologie treatment of child and adolescent depression. Psychiatric Clinics of North America, 15, 29–40.
Ryan, N. D., Williamson, D. E., Iyengar, S., Orvaschel, H., Reich, T., Dahl, R. E., & Puig-Antich, J. (1992). A secular increase in child and adolescent onset affective disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 600–605.
Safer, D. J., Zito, J. M., & Fine, E. M. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98, 1084–1088.
Schowalter, J. E. (1989). Psychodynamics and medication. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 681–684.
Schreier, H. A. (1998). Risperidone for young children with mood disorders and aggressive behavior. Journal of Child and Adolescent Psychopharmacology, 8(1), 49–59.
Silva, R. R., Munoz, D. M, & Alpert, M. (1996). Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: A meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 352–358.
Simeon, J., Dinicola, V. B., Ferguson, H. B., & Copping, W. (1990). Adolescent depression: A placebo controlled fluoxetine treatment study and follow-up. Progress in Neuropsychopharmacology and Biological Psychiatry, 14, 791–795.
Stein, D. J., Bouwer, C, Hawkridge, S., & Emsley, R. A. (1997). Risperidone augmentation of SSRIs in obsessive compulsive and related disorders. Journal of Clinical Psychiatry, 58(3), 119–122.
Strober, M. (1992). Relevance of early age-of-onset in genetic studies of bipolar affective disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 606–610.
Strober, M., Freeman, R., Rigali, J., Schmidt, S., & Diamond, R. (1992). The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. Journal of the American cademy of Child and Adolescent Psychiatry, 31, 16–20.
Strober, M., Lampert, C, Schmidt, S., & Morrell, W. (1993). The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 34–42.
Strober, M., Morrell, W., Burroughs, J., Lampert, C, Danforth, H., & Freeman, R. (1988). A family study of bipolar I disorder in adolescence: Early onset of symptoms linked to increased familial loading and lithium resistance. Journal of Affective Disorders, 15, 255–268.
Strober, M., Morrell, W., Lampert, C, & Burroughs, J. (1990). Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: A naturalistic study. American Journal of Psychiatry, 147, 457–461.
Strober, M., Schmidt-Lackner, S., Freeman, R., Bower, S., Lampert, C, & DeAntonio, M. (1995). Recovery and relapse in adolescents with bipolar affective illness: A five-year naturalistic prospective follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 724–731.
Thomas, C. R., & Holzer, C. E. (1999). National distribution of child adolescent psychiatrists. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 9–15.
Varley, C. K., & McClellan, J. (1997). Case study: Two additional sudden deaths with tricyclic antidepressants. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 390–394.
Wagner, K. D. (1999). Multisite study of paroxetine versus imipramine and placebo in the treatment of children and adolescents with major depression. Paper presented at Oregon Health Sciences University, June 18.
Walsh, B. T, Greenhill, L. L., Giardina, E. V., Bigger, J. T., Waslick, B. D., Sloan, R. P., Bilich, K., Wölk, S., &
Bagiella, E. (1999). Effects of desipramine on autonomie input to the heart. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1186–1192.
Weiss, G., Hechtman, L., Milroy, T., & Perlman, T. (1985). Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 211–220.
Weithorn, L. A., & Campbell, S. B. (1982). The competency of children and adolescents to make informed treatment decisions. Child Development, 53, 1597–1598.
Weiler, E. B., Weller, R. A., & Fristad, M. A. (1995). Bipolar disorder in children: Misdiagnosis, underdiagnosis, and future directions. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 709–714.
Werry, J. S., & Aman, M. G. (1999). Practitioner’s guide to psychoactive drugs for children and adolescents, 2nd ed. New York: Plenum Medical Book.
West, S. A., McElroy, S. L., Strkowski, S. M., Keck, P. E., Jr., & McConville, B. J. (1995). Attention deficit hyperactivity disorder in adolescent mania. American Journal of Psychiatry, 152, 271–273.
Wilens, T. E., Spencer, T. J., Swanson, J. M., Connor, D. F, & Cantwell, D. (1999). Combining methylphenidate and clonidine: A clinically sound medication option. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 614–619, discussion 619-622.
Wilens, T. E., Biederman, J., Baldessarini, R. J., Geller, B., Schleifer, D., Spencer, T. J., Birmaher, B., & Goldblatt, A. (1996). Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1491–1501.
Wilens, T. E., Biederman, J., Baldessarini, R. J., Puopolo, P. R., & Flood, J. G. (1992). Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 691–698.
Williams, D. T., Mehl, R., Yudofsky, S., Adams, D., & Roseman, B. (1982). The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Journal of the American Academy of Child and Adolescent Psychiatry, 21, 129–135.
Wirshing, D. A., Wirshing, W. C, Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999). Novel antipsychotics: Comparison of weight gain liabilities. Journal of Clinical Psychiatry, 60, 358–363.
Wozniak, J., Biederman, J., Kiely, K., Ablon, J. S., Faraone, S. V., Mundy, E., & Mennin, D. (1995). Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 867–876.
Yudofsky, S., Williams, D., & Gorman, J. (1981). Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes. American Journal of Psychiatry, 138, 218–220.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cheng, K., Myers, K. (2001). Pharmacological Interventions. In: Hersen, M., Van Hasselt, V.B. (eds) Advanced Abnormal Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8497-5_24
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8497-5_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4631-9
Online ISBN: 978-1-4419-8497-5
eBook Packages: Springer Book Archive